Adverse effects of systemic therapy in a patient with urothelial bladder cancer and chronic kidney disease – a case report - Top-Institutions - MDSpire

Adverse effects of systemic therapy in a patient with urothelial bladder cancer and chronic kidney disease – a case report

  • By

  • Martyna Najmrocka

  • Aleksandra Semeniuk

  • Rafał Stec

  • July 2, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Urology
    • Oncology

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Urology
    • Oncology

  • #3

    Taipei Tzu Chi Hospital
    Taipei Tzu Chi Hospital

    Hualien, Taiwan

    Key Differentiators

    • Urology

  • #4

    Academic Medical Center
    Academic Medical Center

    Amsterdam, Netherlands

    Key Differentiators

    • Urology
    • Transplant Surgery

Original Source(s)

Adverse effects of systemic therapy in a patient with urothelial bladder cancer and chronic kidney disease – a case report

  • by Martyna Najmrocka, Aleksandra Semeniuk, Rafał Stec

  • July 2, 2026

Related Content

Pathogenic profiles and antimicrobial resistance in neutropenic acute leukemia patients: diagnostic potential of sTNF-R1 and IL-8

EGP-Net: a lung nodule segmentation network integrating edge guidance and pyramidal multi-scale contextual attention mechanisms

Identification of key genes potentially associated with bladder cancer development by common plasticizers: an integrated transcriptomics and network toxicology study